Anand Patel to Janus Kinase Inhibitors
This is a "connection" page, showing publications Anand Patel has written about Janus Kinase Inhibitors.
Connection Strength
1.571
-
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors. Curr Hematol Malig Rep. 2023 06; 18(3):41-55.
Score: 0.844
-
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
Score: 0.727